Sponsor by Innity

Sponsor by cwyeoh

Sponsor by Nuffnang

Wednesday, June 22, 2011

KLCI Stock - SCIENTX / 4731 - 2011 Quarter 3

Company Info
Market Capital (Capital Size)621,000,000 (Medium)
Par ValueRM 0.50

My Analysis
Forecast P/E now(2.7-0.13)/0.3982 = 6.45 (Moderate)
Target Price3.98+0.13 = 4.11 (PE 10.0, EPS 0.3982, DPS 0.13)
DecisionBUY
Comment
Revenue increased 11.5% and is second consecutive quarter increasing and also higher than preceding year corresponding quarter 21.1%, eps increased 7% and is second consecutive quarter increasing and also higher than preceding year corresponding quarter 21.4%, cash generated from operating enough to cover all expenses and still got 20% extra, weaker liquidity ratio at low level now, lower gearing ratio at moderate level now, all accounting ratio are good
First Support Price2.56
Second Support Price2.45
Risk RatingMODERATE

Research House
TA Target Price3.8 (2011-04-15)

Accounting Ratio
Return on Equity15.34%
Dividend Yield4.07%
Profit Margin11.91%
Tax Rate18.34%
Asset Turnover1.0744
Net Asset Value Per Share2.13
Net Tangible Asset per share2.13
Price/Net Tangible Asset Per Share1.27
Cash Per Share0.18
Liquidity Current Ratio1.456
Liquidity Quick Ratio0.8453
Liquidity Cash Ratio0.1936
Gearing Debt to Equity Ratio0.524
Gearing Debt to Asset Ratio0.3261
Working capital per thousand Ringgit sale11.2%
Days to sell the inventory62
Days to collect the receivables58
Days to pay the payables73

My notes based on 2011 quarter 3 report (number in '000):-
- Higher revenue and pbt is contributed by both manufacturing and property division

- Started construction of its factory which will be ready by end of this year

- The machine installation and test run shall be completed by first half of 2012 and the company is expected to contribute positively thereafter

- Estimate next 4Q eps after 2011 Q3 result announced = 0.0948*4*1.05 = 0.3982, estimate PE on current price 2.7 = 6.45(DPS 0.13)

SCIENTX latest news (English)

SCIENTX latest news (Chinese)

No comments:

Post a Comment